Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Deletes the Melanoma disease reference and the related topics header and MedlinePlus Genetics link from the page. This changes how readers interpret the study focus and locate related background resources.
    Difference
    0.2%
    Check dated 2026-05-11T01:31:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.0 to v3.5.3, indicating a site or release update rather than a change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-26T15:40:04.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic, and MedlinePlus Genetics is listed under related topics to provide disease context and educational resources.
    Difference
    0.2%
    Check dated 2026-04-05T07:26:28.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Removed the core disease term 'Melanoma' and related topics; this reduces essential context for the study and may affect how users understand and locate the page.
    Difference
    0.2%
    Check dated 2026-03-21T20:28:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added links to related topics Melanoma and MedlinePlus Genetics in the study page's related topics section.
    Difference
    0.2%
    Check dated 2026-03-14T12:39:45.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Melanoma is removed from the related topics section. The site revision is updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-07T13:17:52.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.